Ms Eilísh Hardiman:

I can say that because the issues were happening in 2021, the matters and issues in the report were known to management and they were raised with the HSE through the appropriate channels. Several of them were raised before the report was finalised. While the report itself was not shared because it was confidential and was regarded as that, what is most important here, particularly around patient safety matters, is that the matters were raised through the appropriate channels, thankfully, and we worked with the HSE to address the key risk issues involved.